FNM Second Quarter 2025 Earnings: EPS: €0.069 (vs €0.04 in 2Q 2024)

FNM (BIT:FNM) Second Quarter 2025 Results

Key Financial Results

• Revenue: €235.6m (up 6.5% from 2Q 2024).
• Net income: €29.8m (up 78% from 2Q 2024).
• Profit margin: 13% (up from 7.6% in 2Q 2024).
• EPS: €0.069 (up from €0.04 in 2Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

FNM Earnings Insights

Looking ahead, revenue is expected to decline by 9.5% p.a. on average during the next 3 years, while revenues in the Transportation industry in Europe are expected to grow by 1.5%.

Performance of the market in Italy.

The company's share price is broadly unchanged from a week ago.

Valuation

Our analysis of these results suggests FNM may be undervalued based on 6 important criteria we look at. To access our thorough examination of analyst consensus click here and discover the expected future direction of the company.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.